Anticipated shortage

Jardiance 10 mg tablets

empagliflozin · 10 mg tablet

Jardiance

Reported
20 March 2025
Expected resolution
30 September 2025
TGA reference
TGA-MSI-2025-024
Sponsor
Boehringer Ingelheim Pty Ltd

Reason for shortage

Anticipated shortage due to expanded PBS indications for heart failure and CKD driving increased demand beyond forecast.

What to do

  1. 1.
    Ensure you have adequate stockCollect your current prescription promptly to build a small buffer before the anticipated shortage begins.
  2. 2.
    Speak with your prescriber proactivelyDiscuss alternative options now, before the shortage occurs, so a plan is in place.
  3. 3.
    Monitor TGA updatesAnticipated shortages may be resolved before they become active. Check the TGA MSI database regularly.

Suggested alternatives

Same or related therapeutic class. Always discuss with your doctor or pharmacist before switching.

Official resources

MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.